Following the strange year for the biopharma industry that was 2024, insiders and analysts alike are waiting expectantly to ...

Terms of the deal were not disclosed in the case, which involved the government’s patents on Gilead’s HIV drugs Truvada and ...

Kite Pharma is flying high with the addition of a new member to its senior leadership team. | Kite Pharma is flying high with ...

The FDA established its accelerated approval program in 1992 to allow drugs to reach the market quickly for life-threatening ...